Creating a tool to assess genetic risks in diverse primary care settings.
Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations.
['FUNDING_U01'] · DUKE UNIVERSITY · NIH-10468030
This study is working on a new, easy way for families to share their health history so that people can better understand their risk for inherited health conditions, especially for those who might have trouble with reading or accessing resources.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10468030 on ClinicalTrials.gov |
What this research studies
This research aims to improve the use of family health history (FHH) in identifying individuals at risk for hereditary conditions. It addresses barriers to data collection by developing a user-friendly, scalable risk assessment model that incorporates voice-to-text technology and social networking for family engagement. The approach is designed to be accessible for low literacy and low resource populations, ensuring that more patients can benefit from genetic risk assessments. By enhancing the way FHH is collected and utilized, the research seeks to create actionable care plans for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from low resource settings who may have a family history of hereditary conditions.
Not a fit: Patients with no family history of hereditary conditions or those who are not engaged in primary care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification and management of hereditary conditions in diverse patient populations.
How similar studies have performed: Previous studies have shown that systematic family health history assessments can identify a significant percentage of patients at risk for hereditary conditions, indicating potential success for this approach.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VOORA, DEEPAK — DUKE UNIVERSITY
- Study coordinator: VOORA, DEEPAK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.